Consider This from NPR Folgen

Bills under consideration in dozens of states target trans youth by focusing on two things: health care and sports. Some bills have already become law in states including South Dakota, Mississippi, Tennessee, Arkansas and Alabama. One of the harshest measures is an Alabama, where a bill would make it a felony to provide gender-affirming therapy to anyone under the age of 19. NPR's Melissa Block reports on what that would mean for one trans teenager and his family. University of Pittsburgh professor Jules Gill-Peterson explains what she's uncovered about the history of trans youth in America. She is the author of Histories of the Transgender Child.In participating regions, you'll also hear from local journalists about what's happening in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

The COVID-19 vaccine rollout is giving us all hope that we'll be back to some sense of normal soon, but the pandemic will likely still play a role in what college life looks like next fall. We asked some high school seniors what questions they have about deciding where to go to school and what college life is like during a pandemic. To help with answering those questions and sharing some advice, we hear from two current college freshmen, Ayiana Davis Polen at Spelman College in Atlanta and Adam Ahmad at the University of California, Berkeley, and NPR reporter Elissa Nadworny.In participating regions, you'll also hear from local journalists about what's happening in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Scientists are growing concerned the U.S. may be headed for a fourth wave. COVID-19 cases are rising rapidly, mirroring an increase in many countries around the world. Harvard epidemiologist Bill Hanage tells NPR he's worried another surge in the U.S. will fuel the spread of the variant known as B.1.1.7. In the meantime, there's new evidence that vaccines from Pfizer and Moderna are effective at preventing viral spread — and that they produce "robust" antibody response in children ages 12-15. NPR's Joe Palca has more. In participating regions, you'll also hear from local journalists about what's happening in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy